Jazz Pharmaceuticals shared a post on LinkedIn:
“Innovation in oncology requires continued investment in areas where significant unmet need remains for patients.
Hear from Chumi Khurana, Senior Vice President and Oncology Franchise Head, on our evolving oncology strategy and commitment to advancing science across hematologic malignancies, solid tumors and neuro-oncology.”
Other articles about Neuro-Oncology on OncoDaily.